On Thursday, BofA Securities increased its price target for Rocket Lab USA (NASDAQ:RKLB) shares, setting a new goal of $30, up from the previous $10, while reaffirming its Buy rating on the stock. The revision reflects the firm's confidence in Rocket Lab's advancing capabilities in launch and spacecraft development, which are seen as pivotal in the company's strategy to become a comprehensive end-to-end space provider.
The analyst from BofA Securities highlighted that Rocket Lab's Electron rocket continues to secure bookings and achieve successful launches. Moreover, the development of the Neutron rocket is on track, with its anticipated debut set for 2025. These advancements are key factors behind the elevated price target.
Rocket Lab's Space Systems division has been performing notably well, executing complex missions for significant customers. This success has translated into growth and the creation of new opportunities that surpassed initial expectations. These achievements have been factored into the updated price target.
The increased stock price target to $30 from $10 is also justified by stronger projected free cash flow from Space Systems and improved profitability expectations for the Electron rocket. Additionally, a lower discount rate was applied due to reduced market risk and beta as the Neutron project progresses and Rocket Lab asserts itself as a prime player in the space industry.
The analyst's price objective is derived from an average of bull, base, and bear long-term scenarios, yielding present values of $45, $30, and $15, respectively. This valuation approach underscores the potential high reward, balanced outlook, and possible risks associated with Rocket Lab's stock.
In other recent news, Rocket Lab USA has been the subject of significant developments in the aerospace sector. Both Cantor Fitzgerald and TD Cowen have raised their stock price targets for the company, reflecting confidence in Rocket Lab's potential.
This comes after Rocket Lab's announcement of a multi-launch agreement with a commercial satellite constellation operator for its upcoming Neutron rocket, which is expected to commence launches in mid-2025.
Further, Rocket Lab reported a substantial 55% year-on-year revenue growth in Q3 2024, totaling $105 million. The company also projected Q4 revenue to be between $125 million and $135 million, with GAAP gross margins anticipated at 26% to 28%. Despite these positive revenue forecasts, an adjusted EBITDA loss for Q4 is expected to range from $27 million to $29 million.
Rocket Lab's Neutron rocket continues to be a significant part of its growth strategy, with the company securing orders for its third and fifth Neutron launches in 2026-27. The company's gross margins have also improved for three consecutive quarters, and it has over 40 launches in its backlog. These recent developments reflect Rocket Lab's progression in the aerospace sector and its strategic position in the commercial and defense sectors.
InvestingPro Insights
Rocket Lab USA's recent performance aligns with BofA Securities' bullish outlook. According to InvestingPro data, the company has shown impressive revenue growth of 53.92% over the last twelve months as of Q3 2023, with quarterly revenue growth reaching 54.9% in Q3 2023. This strong growth trajectory supports the analyst's positive view on the company's expanding capabilities and market position.
InvestingPro Tips highlight that Rocket Lab holds more cash than debt on its balance sheet and has liquid assets exceeding short-term obligations, indicating a solid financial foundation to support its ambitious projects like the Neutron rocket development. However, investors should note that the company is not currently profitable, with an adjusted operating income of -$186.13 million over the last twelve months.
The stock's recent performance has been remarkable, with a 335.88% price return over the past year and a 90.59% return in the last month alone. This surge aligns with the analyst's increased price target, though it's worth noting that the RSI suggests the stock may be in overbought territory.
For investors seeking a more comprehensive analysis, InvestingPro offers 14 additional tips for Rocket Lab USA, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.